Success Stories: NIW Petition Approved by Texas Service Center for Petitioner from Turkey in the Field of Molecular Biology
Client’s Testimonial:
“We are so lucky to [have] worked with you.”
On March 11th, 2016, we received another EB-2 NIW (National Interest Waiver) approval for a Petitioner in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Petitioner
Country of Origin: Turkey
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Tennessee
Approval Notice Date: March 11th, 2016
Processing Time: 1 month, 21 days
A gifted molecular biologist from Turkey engaged the expert services of North America Immigration Law Group (WeGreened.com) to file an EB-2 NIW (National Interest Waiver) petition on her behalf. She knew of our firm’s stellar approval rates and wanted to give herself a good chance at getting one step closer to a green card. As is apparent from the approval notice that we received a mere month and 18 days after we submitted the EB-2 NIW petition, we accomplished what we were hired to do.
EB-2 NIW Petition Dossier:
Our client’s M.Sc. and Ph.D. in Molecular Biology have equipped her with the knowledge to carry out original research on human and molecular genetics. The results her research yielded contribute to the scientific understanding of the effect of mutations in genomes, and reveal the molecular pathology of pediatric disorders. We established that her work is crucial to the United States medical sector as it helps medical experts understand and treat rare genetic disorders. We backed up our claim by incorporating data on the 51 citations gathered from her work and the 12 scientific papers she had published when we filed her NIW petition. We also included recommendation letters furnished by other expert molecular biologists. These letters served as evidence that our client’s research is relevant to other scientists who are working on similar research topics. Here are several compelling quotes extracted from three of these letters:
- “Including [Client] in the United States’ forthcoming research into rare disease diagnosis is in the best interests of the country. Her continued contributions to research in this area are important for ensuring that the number of patients with rare diseases that receive a misdiagnosis decreases. This is important for reducing the costs of healthcare and misdiagnosis for the country, as well as the costs of misdiagnosis to personal and public health…”
- “[Client] has been performing outstanding research in the field of rare and undiagnosed diseases. She has been involved in projects that seek to determine the genetic causes of rare pediatric disorders in newborn children with unclear clinical diagnoses.”
- “[Client] is a uniquely qualified individual that has made contributions of immeasurable value and benefit to the field.”